-

NUTANIX SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Nutanix, Inc. - NTNX

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 13, 2023 to file lead plaintiff applications in a securities class action lawsuit against Nutanix, Inc. (NasdaqGS: NTNX), if they purchased the Company’s securities between September 21, 2021 and March 6, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

What You May Do

If you purchased securities of Nutanix and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-ntnx/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by June 13, 2023.

About the Lawsuit

Nutanix and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On March 6, 2023, the Company disclosed that it did not expect to be able to timely file its 10-Q Report for the quarter ended January 31, 2023 due to an ongoing Audit Committee investigation into “certain evaluation software from one of its third-party providers [being] instead used for interoperability testing, validation and customer proofs of concept over a multiyear period,” which would likely result in additional costs being incurred to pay for the use of the software beyond the scope of its intended evaluation usage.

On this news, shares of Nutanix fell $2.27 per share, or 7.89%, to close at $26.50 per share on March 7, 2023.

The case is Gorsline v. Nutanix, Inc., et al., No. 23-cv-01827.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.

To learn more about KSF, you may visit http://ksfcounsel.com/.

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

Industry:

Kahn Swick & Foti, LLC

NASDAQ:NTNX
Release Versions
English

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

More News From Kahn Swick & Foti, LLC

Maplebear Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maplebear Inc. d/b/a Instacart - CART

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Maplebear Inc. d/b/a Instacart (NasdaqGS : CART). In December 2025, the U.S. Federal Trade Commission (FTC) announced a $60 million penalty against the company as a result of “deceiving consumers with false advertising, failure to provide refunds and unlawful subscription...

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Lantheus Holdings, Inc. (NasdaqGM: LNTH). In August of 2025, contrary to the Company’s prior optimistic outlook for the growth potential of its flagship product, Pylarify, the Company disclosed an 8% year-over-year decline in Pylarify revenue, as well as cuts to its full-...

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Inspire Medical Systems, Inc. (NYSE: INSP). In August of 2025, contrary to the Company’s repeated assurances that it had met all regulatory, technical, and commercial prerequisites for the launch of its Inspire V device, the Company disclosed that the launch faced an "elo...
Back to Newsroom